International Journal of Clinical Research

Objective To explore the impact of standardized prenatal management on blood glucose control and pregnancy outcomes in patients with gestational diabetes mellitus (GDM). Methods A total of 90 GDM patients admitted to our hospital from January 2022 to December 2023 were selected as the study subjects and randomly divided into a control group (45 cases) and an observation group (45 cases) using a random number table. The control group received routine outpatient management, while the observation group received standardized prenatal management. The blood glucose indicators (fasting blood glucose, 2-hour postprandial blood glucose), maternal and neonatal complication rates, and neonatal outcomes were compared between the two groups. Results Before management, there was no statistically significant difference in blood glucose indicators between the two groups (P > 0.05). After management, the fasting blood glucose (6.12 ± 0.86 mmol/L) and 2-hour postprandial blood glucose (8.05 ± 1.14 mmol/L) in the observation group were lower than those in the control group (7.58 ± 1.20 mmol/L, 11.32 ± 1.67 mmol/L, respectively) (P < 0.05). The overall maternal and neonatal complication rate in the observation group (8.89%) was lower than that in the control group (28.89%) (P < 0.05). The incidence of adverse outcomes such as neonatal hypoglycemia and macrosomia in the observation group (6.67%) was lower than that in the control group (24.44%) (P < 0.05). Conclusion Standardized prenatal management for GDM patients can effectively control blood glucose levels, reduce the risk of maternal and neonatal complications, and improve pregnancy outcomes, making it worthy of promotion and application in secondary hospitals.

Gestational diabetes; Pregnancy management; Blood glucose control; Pregnancy outcomes; Maternal and neonatal complications